NEW YORK (GenomeWeb) – Caris Life Sciences and North Shore Hematology Oncology Associates today announced they will create a personalized cancer care program leveraging Caris' tumor profiling service for patients in the Long Island, New York area.
George Mason University researcher Emanuel Petricoin and venture capitalist Dendy Young have partnered on a concierge medicine company aimed at bringing personalized cancer treatment to the community hospital setting.
NEW YORK (GenomeWeb News) – Caris Life Sciences today announced a distribution deal with IPS Genomix to provide patients access to Caris' tumor profiling service in certain Middle Eastern and African markets.
Nancy Kelley has stepped down from her post as founding executive director of the New York Genome Center. Kelley had been the driving force behind the center's creation and last November had also taken on the role of chief operating officer.
Caris Life Sciences has added next-generation sequencing on the Illumina MiSeq to the array of molecular tumor profiling technologies it uses to help guide cancer therapy, including fluorescence in situ hybridization, PCR, and immunohistochemistry.
Enzo Begins Marketing Dx Test for Early Lung Cancer Detection
Enzo Clinical Labs this week launched a diagnostic test to help oncologists detect lung cancer early and gauge which patients are at heightened risk for disease progression.